ReachBC logo

Research Study

PCOS study of Cyclic P4 and Spironolactone

Innovative Therapy for Women with PCOS

Closed Recruitment

Health Areas

Other Endocrine System, Sexual Health, Other General Health , Public Health, Anxiety

Study Purpose

New evidence says that polycystic ovary syndrome (PCOS) is caused by fast brain signals leading to fast luteinizing hormone (LH) pulses. Progesterone in the menstrual cycle slows LH pulsing. That means ovulation can occur, testosterone levels can go down and regular cycles occur. However, we don't know if this treatment with cyclic progesterone in PCOS will improve women's quality of life.

Details

Women will take the natural hormone, progesterone 14 days a month for 6 months. It is likely to cause regular flow. After one month, women will start the second medicine, that blocks testosterone. To study the effects of these new PCOS therapies, we will test morning saliva, temperature, and a small blood test the beginning and end of the study. Each night before going to bed, women will record their everyday experiences.

location

Lower Mainland

recruitment end date

2023-01-30

eligibility

Age: 19 Years - 40 Years Old

Accepting Healthy Volunteers: No

Research Team Information

Principal investigator

Jerilynn Prior

health authority affiliation

No Health Authority Affiliation

academic affiliation

University of British Columbia - Vancouver

Are you a researcher?

REACH BC can help you connect with volunteers for your research studies.

Privacy and Security

REACH BC will not release any of your personal information to third parties, participating organizations and/or other institutions. Your information will only be available to the researcher(s) after you indicate interest in being contacted about a particular study.

If you have questions or concerns, please

or view our

Michael Smith Health BC Logo

© Copyright 2022 REACH BC